Zymergen Investor Relations Material
Latest events
Status Update
Zymergen
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Zymergen Inc
Access all reports
Zymergen Inc. designs, develops, and commercializes microbes, molecules, and materials for research in the life sciences. It offers a solution that automates biology experiments; a suite of software tools for automation of plants and facilities; hardware components comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; automation control software; and integrated automation systems with parts and services. The company also provides reagent bottles and automated dispensing systems, as well as small molecule screening and process development platform comprising single cell engineered microorganisms with tool kits for analysis. In addition, it offers consulting and advisory services comprising process design to manufacturing services using its solutions for process development, strain engineering, microbial characterization, culture media development, fermentor vessel design and validation services.
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
ZY
Country
πΊπΈ United States